Mission
To develop RNA-based strategies that target multiple cancer survival signals simultaneously, reducing tumor adaptability and resistance to improve the effectiveness and durability of treatments.

Vision
A future where cancer therapies are resilient against tumor adaptation, offering patients longer-lasting responses and improved outcomes.

Values

Innovation: Pioneering multi-target RNA therapeutics to overcome treatment resistance.

Impact: Focusing on solutions that improve patient outcomes and quality of life.

Scientific Rigor: Grounding all strategies in robust, reproducible research.

Collaboration: Leveraging interdisciplinary expertise to tackle complex cancer networks.

​

🔬 Elham Dianati, Ph.D.
Research Officer – Cell & Molecular Biology
• Leads experimental validation of smartRNAs
• Oversees screening in cancer cell lines (PDCs)
• Develops delivery systems

💻Francois Major, Ph.D.
Full Professor of Computer Science and Operations Research, and Founder of
the Laboratories of Computational and Theoretical Biology (DIRO, 1994) and
RNA Engineering (IRIC, 2005)
• Leads computational development
• Develops smartDesign, RIMap, and RINet